As Chapman states,1 outpatient parenteral antibiotic therapy (OPAT) is increasingly seen as a viable management option for high risk patients with infective endocarditis. But in most studies treatment success is judged on clinical grounds (such as cure of infection). Because the benefits of this treatment derive from avoiding hospital admission while providing high standards of care to “low risk” patients, judgment on the …